Beta-Blockers for Acute Myocardial Infarction

The Quality Improvement Support Collaborative has issued a practice advisory and fact sheet about the COMMIT/CCS-2 trial on beta blocker use for myocardial infarction within 24 hours of admission to the hospital. The goal of the Collaborative is to improve the 30-day outpatient mortality for myocardial infarction (MI) patients.

The Collaborative consists of the Agency for Healthcare Research and Quality (AHRQ), the American College of Cardiology (ACC), American Heart Association (AHA), Centers for Medicare and Medicaid Services (CMS), and the Joint Commission on Accreditation of Healthcare Organizations (JCAHO).

Select to access:

American College of Cardiology Foundation
American Health Association
Agency for Healthcare Research and Quality
Centers for Medicare & Medicaid Services
Joint Commission of Healthcare Organizations

May 2005

Internet Citation:

Questions and Answers: Beta-Blockers for Acute Myocardial Infarction. April 27, 2005. Agency for Healthcare Research and Quality, Rockville, MD.

Return to Outcomes & Effectiveness
AHRQ Home Page
Department of Health and Human Services